Praconase

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePraconase
Drug Alias NameCethrinVX-210BA-210
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioaxone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioaxone Biosciences IncVertex Pharmaceuticals IncorporatedAlseres Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A